Oncology Tube - Most Viewed

Dr Alexander Kamb - Executive Director Oncology for Amgen

Sat, 16 Apr 2011 10:16:54 -0600

Alexander received his AB from Harvard University and his PhD from Caltech. After a postdoctoral fellowship at UCSF, he worked in the biotechnology field for about ten years, specializing in the genet...

Author: feeds
Added: 04/16/2011

AUA 2010 interview of Dr. Tom Lue, MD professor of Urology at UCSF talks about Peyronie's disease

Tue, 01 Jun 2010 21:14:58 -0600

American Urology Association 2010 interview of Dr. Tom Lue, MD professor of Urology at UCSF talks about Peyronie's disease.

Author: imedex
Added: 06/01/2010

Cathy Eng, MD, FACP, ASCO GI 2010

Mon, 01 Feb 2010 13:48:50 -0700

Dr Axel Grothey interviews Dr. Cathy Eng from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on clinica...

Author: imedex
Added: 02/01/2010

Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses small renal masses: partial nephrectomy

Mon, 05 Apr 2010 12:36:27 -0600

Eighth International Kidney Cancer Symposium - Paul Russo, M.D. For more in this series: http://www.KidneyCancer.TV.... Disclosure of our financials and corporate sponsors of our website and videos is fr...

Author: kidneycancer
Added: 04/05/2010

Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, discusses Renal Cell Cancer-Surgical management & high risk disease.

Mon, 08 Mar 2010 17:09:46 -0700

Dr. Paul Russo, MD Memorial Sloan-Kettering Cancer Center, New York discusses Renal Cell Cancer-Surgical management & high risk disease at the ASCO GU Conference 2010 Direct Link... http://elc.ime......

Author: imedex
Added: 03/08/2010

Wells Messersmith, MD, ASCO GI 2010

Mon, 01 Feb 2010 13:54:56 -0700

Dr Axel Grothey interviews Dr. Wells Messersmith from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on...

Author: imedex
Added: 02/01/2010

ESMO 2010 - Dr. Ross Camidge, MD discusses Clinical Activity of Crizotinib (PF-02341066), in ALK-Positive Patients with Non-Small Cell Lung Cancer (NSCLC)

Sun, 10 Oct 2010 20:30:36 -0600

Dr. Ross Camidge, MD discusses Clinical Activity of Crizotinib (PF-02341066), in ALK-Positive Patients with Non-Small Cell Lung Cancer (NSCLC)

Author: esmo2010
Added: 10/10/2010

Dr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses Novel Therapies for Prostate Cancer

Mon, 08 Mar 2010 18:54:31 -0700

Dr. Michael Morris, MD, Memorial Sloan-Kettering Cancer Center discusses Novel Therapies for Prostate Cancer at ASCO GU Conference from San Francisco. Direct Link...http://elc.imedex.com/?proj......

Author: imedex
Added: 03/08/2010

Deborah Armstrong, MD, Johns Hopkins Kimmel Cancer Center, discusses Early studies of enzastaurin and bevacizumab.

Mon, 22 Mar 2010 16:57:14 -0600

Full interview...
http://elc.imedex.com/?proj...

* Early studies of enzastaurin and bevacizumab
* Single nucleotitde polymorphisms (SNPs)
* BRCA1 and association with clinical...

Author: imedex
Added: 03/22/2010

Thomas J. Herzog, MD, Columbia University College of Physicians and Surgeons talks about liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced malignancy.

Mon, 22 Mar 2010 15:57:46 -0600

Full interview...
http://elc.imedex.com/?proj...

* Liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced malignancy
* Erlotinib in squamous cell carcinoma...

Author: imedex
Added: 03/22/2010

Gastrointestinal Malignancies - OncoFacts from ASCO 2010 (COIN trial, fluoropyrimidine-oxaliplatin, cetuximab, XELOX-bevacizumab, European Organisation for Research and Treatment of Cancer, CLOCC trial, FOLFOX, trial N0147, KRAS mutations, bevacizuma

Wed, 14 Jul 2010 22:20:13 -0600

Abstracts 3502 and 3525
Investigators from the UK Medical Research Council (MRC) presented results of their COIN trial in which 2500 patients with advanced colorectal cancer were randomized to contin...

Author: imedex
Added: 07/14/2010

OncoFacts Lung Cancer - ASCO 2010 Overview (Crizotinib, paclitaxel-carboplatin, figitumumab, Mapatumumab, paclitaxel-carboplatin, paclitaxel-carboplatin-mapatumumab, NOV-002, NSCLC, CALGB 30406, gemcitabine-carboplatin)

Wed, 14 Jul 2010 23:10:50 -0600

Abstract 3 and LBA7502
Crizotinib is a small molecule EML4/ALK and MET inhibitor that was evaluated in a phase II trial that enrolled 82 patients pre-selected by the presence of the EML4/ALK fusion o...

Author: imedex
Added: 07/14/2010

Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, Discusses Bladder Cancer and Rare GU Tumors

Mon, 08 Mar 2010 12:18:51 -0700

Dr. Dean F. Bajorin, MD Memorial Sloan-Kettering Cancer Center, in New York Discusses Bladder Cancer and Rare GU Tumors at the ASCO Genitourinary Conference in San Francisco.
Direct link...http://el......

Author: imedex
Added: 03/08/2010

Andrew X. Zhu, MD, PhD - ASCO GI 2010

Mon, 01 Feb 2010 13:44:09 -0700

Dr Axel Grothey interviews Dr. Andrew X. Zhu from the 2010 Gastrointestinal Cancers Symposium in Orlando, Florida about important data released at the meeting, highlighting the potential impact on cli...

Author: imedex
Added: 02/01/2010

ASCO 2010 Highlights (American Society of Clinical Oncology) Dr. Bradley Monk MD of the University of California Irvine talks about gynecological oncology, GOG 218, ovarian cancer, and angiogenesis.

Wed, 09 Jun 2010 10:28:23 -0600

ASCO 2010 Highlights (American Society of Clinical Oncology) Dr. Bradley Monk MD of the University of California Irvine talks about gynecological oncology, GOG 218, ovarian cancer, and angiogenesis.
...

Author: imedex
Added: 06/09/2010